ACCELERON PHARMA INC. Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset
ACCELERON PHARMA INC. had Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset of $0 as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountAsset · last filed 2021-02-25
- 2020-12-31: Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset $0.00.
- 2019-12-31: Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset $0.00.
- 2018-12-31: Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset $0.00.
- 2017-12-31: Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset $0.00.
| Period end | Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2018-12-31 | $0.00 10-K · filed 2019-02-27 |
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-01 |
| 2015-12-31 | $0.00 10-K · filed 2016-02-25 |
| 2014-12-31 | $0.00 10-K · filed 2015-03-02 |
| 2013-12-31 | $0.00 10-K · filed 2014-03-17 |